A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...

Disagreements about budgets can delay or stall drug development. As the clinical research industry experiences unprecedented rises in costs, having the most current data available when creating and ...

Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...